Genome-wide association studies have identified multiple risk alleles in the IL-2/IL-2R signaling pathway that are associated with increased susceptibility to diseases such as T1D, MS, SLE, RA, Crohn’s disease, Graves’ disease, and alopecia areata (13). This evidence concerns the gene IL2 and type 1 diabetes mellitus.